1. ScholarBank@NUS
  2. 1. Staff
  3. Staff Publications
Please use this identifier to cite or link to this item: https://doi.org/10.1016/S0957-4166(99)00106-8
DC FieldValue
dc.titleSynthesis and anti-cancer activities of a pair of enantiomeric gold(I) complexes containing sulfanyl-substituted P-stereogenic phosphines
dc.contributor.authorSong, Y.
dc.contributor.authorVittal, J.J.
dc.contributor.authorSrinivasan, N.
dc.contributor.authorChan, S.-H.
dc.contributor.authorLeung, P.-H.
dc.date.accessioned2014-06-23T05:51:12Z
dc.date.available2014-06-23T05:51:12Z
dc.date.issued1999-04-23
dc.identifier.citationSong, Y., Vittal, J.J., Srinivasan, N., Chan, S.-H., Leung, P.-H. (1999-04-23). Synthesis and anti-cancer activities of a pair of enantiomeric gold(I) complexes containing sulfanyl-substituted P-stereogenic phosphines. Tetrahedron Asymmetry 10 (8) : 1433-1436. ScholarBank@NUS Repository. https://doi.org/10.1016/S0957-4166(99)00106-8
dc.identifier.issn09574166
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/77125
dc.description.abstractA pair of enantiomeric gold(I) complexes containing enantiomerically pure 2,3-dimethyl-7-phenyl-5-(phenylsulfanyl)-7-(R/S)- phosphabicyclo[2.2.1]hept-2-ene has been prepared and in vitro cytotoxicity tests showed that both the enantiomers are relatively nontoxic against healthy lymphocytes, but are highly potent against suspension and monolayer human tumor cell lines.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/S0957-4166(99)00106-8
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentCHEMISTRY
dc.description.doi10.1016/S0957-4166(99)00106-8
dc.description.sourcetitleTetrahedron Asymmetry
dc.description.volume10
dc.description.issue8
dc.description.page1433-1436
dc.description.codenTASYE
dc.identifier.isiut000080753100003
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.